Skip to content
Home/Companies/Biotech/EG 427

EG 427

Biotech·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns EG 427?

EG 427 is a French Biotech company, currently owned by Andera Partners since 2025.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Investor
Andera Partners
BioDiscovery 7 · 2025 · VC

Key facts

HQFrance
SectorBiotech

More from BioDiscovery 7

Other portfolio companies in the same fund.

Alveus Therapeutics
Alveus Therapeutics
Active
BiotechFrance· 2026
Basis
Active
· 2026
Rivermark Medical
Active
MedTechUS· 2026
Spiro Medical
Spiro Medical
Active
MedTechFrance· 2026
Adcytherix
Active
BiotechFrance· 2025
Bioptimus
Bioptimus
Active
BiotechFrance· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns EG 427?

EG 427 is currently owned by Andera Partners, through BioDiscovery 7, since 2025.

When did Andera Partners acquire EG 427?

Andera Partners acquired EG 427 in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue